Долгая жизнь с муковисцидозом

Rotter JB. Social learning and clinical psychology. Englewood Cliffs, New Jersey: Prentice Hall; 1954.

626

Seligman МЕР. Helplessness: on development, depression and death. San Francisco: W. H. Freeman and Company; 1975.

627

Bandura A. Self-efficacy the exercise of control. San Francisco: W. H Freeman and Company; 1997.

628

Rotter JB. Social learning and clinical psychology. Englewood Cliffs, New Jersey: Prentice Hall; 1954.

629

Seligman МЕР. Helplessness: on development, depression and death. San Francisco: W. H. Freeman and Company; 1975.

630

Bandura A. Self-efficacy the exercise of control. San Francisco: W. H Freeman and Company; 1997.

631

Mishali M, Omer H, Heymann AD. The importance of measuring self-efficacy in patients with diabetes. Fam Pract 2011; 28: 82-7.

632

Quittner AL, Barker DH, Snell C, et al. Prevalence and impact of depression in cystic fibrosis. Curr Opin Pulm Med 2008; 14: 582-8.

633

Cramm JM, Strating MM, Roebroeck ME, et al. The importance of general self-efficacy for the quality of life of adolescents with chronic conditions. Soc Indie Res 2013; 113:551-61.

634

Grieve AJ, Tluczek A, Racine-Gilles CN, et al. Associations between academic achievement and psychosocial variables in adolescents with cystic fibrosis. J Sch Health 2011; 81: 713-20.

635

Lazarus R, Folkman S. Stress, appraisal and coping. New York: Springer; 1984.

636

Zimmer-Gembeck MJ, Skinner EA. The development of coping across childhood and adolescence: an integrative review and critique of research. Int J Behav Dev2011;35: 1-17.

637

Graue M, Wentzel-Larsen T, Bru E. The coping styles of adolescents with type 1 diabetes are associated with degree of metabolic control. Diabetes Care 2004; 27: 1313-7.

638

Anie KA, Steptoe A, Bevan DH. Sickle cell disease: pain, coping and quality of life in a study of adults in UK. Br J Health Psychol 2002; 7(Pt3): 331-44.

639

Abbott J, Hart A, Morton A, et al. Health-related quality of life in adults with cystic fibrosis: the role of coping. J Psychosom Res 2008; 64: 149-57.

640

Taylor JL, Smith PJ, Babyak A, et al. Coping and quality of life in patients awaiting lung transplantation. J Psychosomatic Res 2008; 65: 71-9.

641

Abbott J, Dodd M, Gee L, et al. Ways of coping with cystic fibrosis: implications for treatment adherence. Disabil Rehabil 2001; 23:315-24.

642

Buytendijk FJJ (1948 original). De la douleur. Translated into French. Paris: PUF; 1951.

643

Vannotti M, Celis-Gennart M. L'experience plurielle de la maladie chronique. Maladie pulmonale etfamille. In: Corps ettherapie familiale. Cahiers critiques de therapie familiale et de pratique de reseaux. Bruxelles De Boeck-Universite; 1999; 113-38.

644

Paterson B.The shifting perspectives model of chronic illness. J Nurs Scholarsh 2001; 33: 21-6.

645

Strauss GD, Wellish DK. Psychological adaptation in older CF patients. J Chronic Dis 1981; 34: 141-6.

646

Conway SP, Pond MN, Hamnet T, et al. Compliance with treatment in adult patients with CF. Thorax 1996;51:29–33.

647

Dziuban EJ, Saab-Abazeed L, Chaudhry SR, et al. Identifying barriers to treatment adherence and related attitudinal patterns in adolescents with cystic fibrosis. Pediatr Pulmonol 2010; 45: 450-8.

648

Sawicki GS, Heller KS, Demars N, et al. Motivating adherence among adolescents with cystic fibrosis: Youth and parent perspectives. Pediatr Pulmonol 2015; 50: 127-36.

649

Quittner AL, Zhang J, Marynchenko M, et al. Pulmonary medication adherence and healthcare use in cystic fibrosis. Chest 2014; 146:142-51.

650